Reduction of Serum Testosterone Levels During Chronic Glucocorticoid Therapy
- MICHAEL R. MacADAMS, M.D.;
- RICHARD H. WHITE, M.D.; and
- BRADLEY E. CHIPPS, M.D.
Abstract
The effect of chronic glucocorticoid therapy on serum testosterone levels was studied in men aged 67 ± 4 (SD) years with chronic pulmonary disease. The serum testosterone level was reduced in 14 of 16 patients to a mean value of 211 ± 93 ng/dL, compared with 449 ± 111 ng/dL in 11 age- and disease-matched control patients (p < 0.001). The corticosteroid dosage and the serum testosterone level were inversely related (r = -0.78). Testosterone binding to serum proteins was not significantly affected. Basal gonadotrophin levels were not elevated while their secretory responses to exogenous gonadotrophin-releasing hormone (GnRH) were intact. We conclude that glucocorticoid therapy commonly reduces serum testosterone levels in older men due to alteration of hypothalamic GnRH secretion.
Article and Author Information
-
▸From the Division of General Medicine, Department of Internal Medicine, University of California, Davis; Sacramento, California.
-
▸Requests for reprints should be addressed to Michael R. MacAdams, M.D.; 2600 Capitol Avenue, Suite 406; Sacramento, CA 95816.
- © 1986 American College of Physicians
RSS Feeds









